Protein detail

TNR8

Tumor necrosis factor receptor superfamily member 8 (CD30L receptor) (Ki-1 antigen) (Lymphocyte activation antigen CD30) (CD antigen CD30)

Entry name
TNR8
UniProt ID
EVMP confidence score
0.38
Supporting publications (n)
2
Transmembrane count
1
Protein classification
Cancer-related genesCD markersFDA approved drug targetsPlasma proteinsPredicted intracellular proteinsPredicted membrane proteins
EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information13
Protein Names
Tumor necrosis factor receptor superfamily member 8 (CD30L receptor) (Ki-1 antigen) (Lymphocyte activation antigen CD30) (CD antigen CD30)
Protein Class (6)
Cancer-related genesCD markersFDA approved drug targetsPlasma proteinsPredicted intracellular proteinsPredicted membrane proteins
Protein Function (4)
  • Cancer-related genes:Candidate cancer biomarkers
  • CD markers
  • Predicted intracellular proteins
  • FDA approved drug targets:Biotech drugs
Transmembrane
386..406; Helical
Transmembrane Count
1
Entrez Gene Symbol
Gene Synonym (3)
CD30D1S166EKI-1
Gene Description
TNF receptor superfamily member 8
Chromosome
1
Position
12063303-12144207
Supporting publications (n)
2
EVMP confidence score
0.38
Fluorescence & Localization2
Tissue SpecifictestisCell SpecificAlveolar cells type 1
Function & Pathway7
Relations & Evidence72

Ligand-Receptor Signaling (67)

67 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
receptorreceptorBaccin2019NoYesNoYesNo
tumor_necrosis_factorreceptorAlmen2009NoYesNoYesNo
tnf_receptorreceptorCellPhoneDBNoYesNoYesNo
cytokinereceptorBaccin2019NoYesNoYesNo
tnf_ngfreceptorHPMRNoYesNoYesNo
tnr8_tnf_ngfreceptorHPMRNoYesNoYesNo
tnfngfreceptorSurfaceomeNoYesNoYesNo
cytokinereceptorICELLNETNoYesNoYesNo
cytokine_tnfreceptorICELLNETNoYesNoYesNo
receptorreceptorOmniPathNoYesNoYesNo
Page 2 of 7PreviousNext

Protein Complex Composition (4)

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Protein Organic Solvent PrecipitationMass spectrometry132384937
Sequence, Structure & Domains11

Sequences

Length
595
Mass
63,747
Sequence
MRVLLAALGLLFLGALRAFPQDRPFEDTCHGNPSHYYDKAVRRCCYRCPMGLFPTQQCPQRPTDCRKQCEPDYYLDEADRCTACVTCSRDDLVEKTPCAWNSSRVCECRPGMFCSTSAVNSCARCFFHSVCPAGMIVKFPGTAQKNTVCEPASPGVSPACASPENCKEPSSGTIPQAKPTPVSPATSSASTMPVRGGTRLAQEAASKLTRAPDSPSSVGRPSSDPGLSPTQPCPEGSGDCRKQCEPDYYLDEAGRCTACVSCSRDDLVEKTPCAWNSSRTCECRPGMICATSATNSCARCVPYPICAAETVTKPQDMAEKDTTFEAPPLGTQPDCNPTPENGEAPASTSPTQSLLVDSQASKTLPIPTSAPVALSSTGKPVLDAGPVLFWVILVLVVVVGSSAFLLCHRRACRKRIRQKLHLCYPVQTSQPKLELVDSRPRRSSTQLRSGASVTEPVAEERGLMSQPLMETCHSVGAAYLESLPLQDASPAGGPSSPRDLPEPRVSTEHTNNKIEKIYIMKADTVIVGTVKAELPEGRGLAGPAEPELEEELEADHTPHYPEQETEPPLGSCSDVMLSVEEEGKEDPLPTAASGK
Alternative Products
Event=Alternative splicing, Alternative initiation; Named isoforms=3; Name=1; Synonyms=Long; IsoId=P28908-1; Sequence=Displayed; Name=2; Synonyms=Cytoplasmic, Short, C30V; IsoId=P28908-2; Sequence=VSP_018900; Name=3; IsoId=P28908-3; Sequence=VSP_055032, VSP_055033
Alternative Sequence
1..463; Missing (in isoform 2); 1..111; Missing (in isoform 3); 446; Missing (in isoform 3)

3D Structural Models

3D Structure
X-ray crystallography (1)

Domain & Motif Annotations

Compositional Bias
179..194; Low complexity; 346..355; Polar residues; 443..452; Polar residues; 499..509; Basic and acidic residues
Repeat
28..66; TNFR-Cys 1; 68..106; TNFR-Cys 2; 107..150; TNFR-Cys 3; 205..241; TNFR-Cys 4; 243..281; TNFR-Cys 5; 282..325; TNFR-Cys 6
Region
167..238; Disordered; 323..355; Disordered; 438..457; Disordered; 485..509; Disordered; 536..595; Disordered
Protein Families
TNFR8 family
Sequence Similarities
Belongs to the TNFR8 family.
Clinical Relevance9
Supporting Publications2
PMIDTitleAbstract
27894104Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.No abstract available
39409015SILAC-Based Characterization of Plasma-Derived Extracellular Vesicles in Patients Undergoing Partial Hepatectomy.No abstract available